TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
radiology reporting EHR health record CDS AUC

Clinicians have a new tool for predicting TAVR mortality

Left atrium emptying fraction (LAEF) measurements can provide significant value during the TAVR planning process.

Real-world TAVR outcomes highlight the accuracy of clinical trials

Clinical trial results don't always apply to real-world patient populations.

Thumbnail

Permanent pacemaker implantation after TAVR does not increase risk of death or heart failure

Prior studies have suggested that TAVR patients could face worse outcomes if they require a permanent pacemaker. 

TAVR safe and effective for patients with cirrhosis

Patients with cirrhosis of the liver often undergo TAVR at a younger age, but the outcomes remain strong. 

Thumbnail

Just 3.6% of TAVR procedures in the US performed by women

In addition, researchers noted, there were no female specialists performing TAVR in 19 states. 

Thumbnail

TAVR and SAVR deliver similar 5-year outcomes for CKD patients

“The choice of intervention in patients with CKD and aortic stenosis is complex and influenced by multiple competing factors," researchers said. 

Next-day discharge after TAVR is safe and effective, new meta-analysis confirms

Researchers tracked data from six different studies, focusing on the likelihood of potential issues such as bleeding and vascular complications.

Thumbnail

TAVR provides comparable value for low-risk patients with bicuspid and tricuspid AS

Researchers examined data from more than 3,000 TAVR procedures performed with balloon-expandable valves. 

Displaying 313 - 320 of 417

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup